BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Tivozanib

0+ PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Tivozanib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

cabozantinib
22 shared targets
golvatinib
22 shared targets
cep
21 shared targets
saracatinib
24 shared targets
dasatinib
17 shared targets
regorafenib
19 shared targets
bafetinib
18 shared targets
lenvatinib
17 shared targets
glesatinib
14 shared targets
ponatinib
27 shared targets
Loading evidence profile...

This evidence profile for Tivozanib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.